SUMMARY Acetaldehyde may be the injurious agent in acute alcoholic liver disease. It has been suggested that the mechanism of liver injury in this situation may be immunologically mediated. In the present study acetaldehyde has been bound to human liver plasma membranes. The activation of C3 by the acetaldehyde/membrane product was measured by immunofixation of the separated C3 components. Activation of C3 by acetaldehyde exposed liver plasma membranes was increased to 16 4% compared with 6% by non-exposed membranes (p=0.004). Human liver plasma membranes bound 212±18 nmol acetaldehyde per mg membrane protein. The binding constant was 439±81 ,uM. It is concluded that acetaldehyde bound to human liver plasma membranes activates the complement sequence and this may be the initial stage in the pathogenesis of acute alcoholic liver disease. 
SUMMARY Acetaldehyde may be the injurious agent in acute alcoholic liver disease. It has been suggested that the mechanism of liver injury in this situation may be immunologically mediated. In the present study acetaldehyde has been bound to human liver plasma membranes. The activation of C3 by the acetaldehyde/membrane product was measured by immunofixation of the separated C3 components. Activation of C3 by acetaldehyde exposed liver plasma membranes was increased to 16 4% compared with 6% by non-exposed membranes (p=0.004). Human liver plasma membranes bound 212±18 nmol acetaldehyde per mg membrane protein. The binding constant was 439±81 ,uM. It is concluded that acetaldehyde bound to human liver plasma membranes activates the complement sequence and this may be the initial stage in the pathogenesis of acute alcoholic liver disease. (Fig. 1) . The native and activated components were precipitated in the gel by layering on the gel a cellulose acetate membrane which had been soaked in the specific anti-human C3 (Atlantic Antibodies, Scarborough, Me, USA). The gels were then soaked in hypertonic saline overnight which washes out all of the non-immunoprecipitated proteins leaving only the C3 components in the gel. The The binding of acetaldehyde to human liver cell plasma membrane vesicles was measured using the incorporation of tritium from tritiated sodium cyanoborohydride as described previously.6
Results Table 1 gives an indication of the purity of the preparation of human liver plasma membranes by this method. The figures indicate that the preparation results in a six-fold concentration of plasma membranes compared with the whole liver homogenate. The purity of the preparation is comparable with that obtained by others in the literature using the same preparative technique. 4 There is significant contamination of the plasma membrane preparation by endoplasmic reticulum. Further purification of the plasma membranes would require a continuous density gradient, the facilities for which are beyond the resources of this laboratory, and the small yield of such highly purified membranes from a single human wedge liver biopsy is likely to preclude C3 activation studies.
Acetaldehyde bound to the human liver plasma membranes (Fig. 2) according to the following parameters:
Amount bound = 212±18 nmol/mg membrane protein (SEM).
The binding constant was 439±81 ,M. Figure 3 illustrates the method used for quantitating the C3 activation measured by the immunofixation technique described.
Experiments were undertaken on membrane preparations from five human livers. The results are shown in Table 2 .
C3 activation by the membranes alone (control membranes) was 6 6% ±2%. When the membranes As with clotting factors, the complement system is unstable in vitro so that some spontaneous activation of C3 does occur (6% in the simultaneous control incubations). The increased activation which results from the pre-exposure of the plasma membranes to acetaldehyde is, however, highly significant.
The concentration of acetaldehyde used in the studies of complement activation was selected to be 1 mM. Dose response studies were not possible because such studies require large amounts of plasma membrane preparations. The availability of human liver from which such preparations could be made was, of course, limited by ethical as well as clinical considerations. The concentration of acetaldehyde in the systemic circulation in alcohol abuse is significantly less thanl mM but there are no data on the intrahepatic concentrations of acetaldehyde which may be achieved during alcohol Fig. 3 Upper trace shows the two peaks ofa densitometric scan from sera incubated with liver plasma membranes. Peak I is native C? (corresponds to the lower bands in Fig.   1 ). Peak 2 is activated C? (upper bands of Fig. 1 abuse. As the binding constant for acetaldehyde on the plasma membranes was shown to be approximately 440 uM, the concentration of acetaldehyde for the complement activation experiments, for which dose dependency studies could not be done, was chosen to be approximately twice the binding constant. At this concentration the binding sites on the plasma membranes might be expected to be saturated thus any effect on complement activation ought to be detected. Previous experiments had indicated that 1 mM free acetaldehyde would cause an activation of C3 of approximately 5%. The thorough washing of the plasma membranes after incubation with acetaldehyde is, however, more than sufficient to remove any unbound acetaldehyde remaining. But if a small trace of free acetaldehyde were to have been carried over with the plasma membranes, in spite of the washing procedure, into the complement containing incubation medium, then this clearly would not be of sufficient concentration to account for the three-fold increase in C3 activation noted in these experiments.
The non-enzymic adduction of acetaldehyde to rat liver cell plasma membranes had previously been demonstrated. 3 6 The experiments reported here indicate that acetaldehyde will also bind to the plasma membranes of normal human liver cells via the formation of an intermediate Schiff base. Although our experiments do not exclude other effects of acetaldehyde on membrane function such as fluidity, or on membrane enzymes such as adenyl cyclase, our experiments in rats3 show that the binding of acetaldehyde to the liver plasma membranes does not affect hepatic function assessed by urea synthesis and gluconeogenesis nor gross membrane function assessed by alanine transport. This finding is compatible with the hypothesis that any injurious effect of acetaldehyde may be mediated by an immune mechanism. The histological picture of the liver in acute alcoholic liver disease in man is, however, quite unlike the histological picture in, for example, primary biliary cirrhosis or chronic active hepatitis which are thought to be immunologically mediated. In these two diseases the cellular infiltrate is located predominantly in the portal tracts and consists mainly of lymphocytes and plasma cells. These histological features are compatible with a cell mediated immune mechanism in the pathogenesis of these diseases. By contrast, in acute alcoholic liver disease the cellular infiltrate is lobular in distribution and consists mainly of polymorphonuclear cells. Thus, although lymphocyte sensitisation has been shown to both acetaldehyde8 and Mallory's hyaline,9 the histological pattern of acute alcoholic liver disease is more suggestive of antibody mediated cytotoxicity. Neuberger et allo have recently presented evidence of circulating antibodies in the serum of patients with alcoholic liver damage against alcohol altered rabbit liver cells. The experiments reported in the present paper, however, indicate that liver cell membranes to which acetaldehyde has been bound will activate the third component of complement in human serum in the absence of antibody.
Complement is a series of proteins which can be activated in sequence to produce terminal active component that causes cell lysis. This cascade of activation of the sequential components may be initiated by the classical or the alternate pathway. Either pathway results in the activation of C3 -the major component of the complement system in the serum. The finding that the plasma membranes of liver cells after exposure to acetaldehyde will active C3 may therefore indicate that this could be the mechanism by which liver cell damage may be initiated in acute alcoholic liver disease, even though presently available analytical techniques have so far failed to demonstrate convincingly any evidence of complement activation in alcoholic liver disease in vivo.
Although complement is classically activated by the complexing of antibody with antigen, the presence of antibody is not essential. Complement may be activated by molecular surface charge or by the surface properties of some proteins. 1 " Subtle changes in the protein's surface properties may influence the molecule's ability to activate complement.12 It has previously been suggested13 that the binding of acetaldehyde to hepatocyte plasma membranes may activate the complement sequence by causing a structural change in the surface of the plasma membrane. This paper presents experimental evidence to indicate that such a mechanism can occur.
If C3 activation by the acetaldehyde/membrane product is the mechanism which initiates liver damage in acute alcoholic liver disease, then the antibodies shown by Neuberger and coworkers'( 
